These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 21091507)

  • 1. Enteropathogenic E. coli non-LEE encoded effectors NleH1 and NleH2 attenuate NF-κB activation.
    Royan SV; Jones RM; Koutsouris A; Roxas JL; Falzari K; Weflen AW; Kim A; Bellmeyer A; Turner JR; Neish AS; Rhee KJ; Viswanathan VK; Hecht GA
    Mol Microbiol; 2010 Dec; 78(5):1232-45. PubMed ID: 21091507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional differences and interactions between the Escherichia coli type III secretion system effectors NleH1 and NleH2.
    Pham TH; Gao X; Tsai K; Olsen R; Wan F; Hardwidge PR
    Infect Immun; 2012 Jun; 80(6):2133-40. PubMed ID: 22451523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial effector binding to ribosomal protein s3 subverts NF-kappaB function.
    Gao X; Wan F; Mateo K; Callegari E; Wang D; Deng W; Puente J; Li F; Chaussee MS; Finlay BB; Lenardo MJ; Hardwidge PR
    PLoS Pathog; 2009 Dec; 5(12):e1000708. PubMed ID: 20041225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EPEC NleH1 is significantly more effective in reversing colitis and reducing mortality than NleH2 via differential effects on host signaling pathways.
    Kralicek SE; Nguyen M; Rhee KJ; Tapia R; Hecht G
    Lab Invest; 2018 Apr; 98(4):477-488. PubMed ID: 29396422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of enteropathogenic Escherichia coli map is significantly different than that of other type III secreted effectors in vivo.
    Nguyen M; Rizvi J; Hecht G
    Infect Immun; 2015 Jan; 83(1):130-7. PubMed ID: 25312947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The enteropathogenic E. coli (EPEC) Tir effector inhibits NF-κB activity by targeting TNFα receptor-associated factors.
    Ruchaud-Sparagano MH; Mühlen S; Dean P; Kenny B
    PLoS Pathog; 2011 Dec; 7(12):e1002414. PubMed ID: 22144899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enterohaemorrhagic Escherichia coli serogroup O111 inhibits NF-(kappa)B-dependent innate responses in a manner independent of a type III secreted OspG orthologue.
    Nobe R; Nougayrède JP; Taieb F; Bardiau M; Cassart D; Navarro-Garcia F; Mainil J; Hayashi T; Oswald E
    Microbiology (Reading); 2009 Oct; 155(Pt 10):3214-3225. PubMed ID: 19628559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attaching and effacing bacterial effector NleC suppresses epithelial inflammatory responses by inhibiting NF-κB and p38 mitogen-activated protein kinase activation.
    Sham HP; Shames SR; Croxen MA; Ma C; Chan JM; Khan MA; Wickham ME; Deng W; Finlay BB; Vallance BA
    Infect Immun; 2011 Sep; 79(9):3552-62. PubMed ID: 21746856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of NF-κB signaling in human dendritic cells by the enteropathogenic Escherichia coli effector protein NleE.
    Vossenkämper A; Marchès O; Fairclough PD; Warnes G; Stagg AJ; Lindsay JO; Evans PC; Luong le A; Croft NM; Naik S; Frankel G; MacDonald TT
    J Immunol; 2010 Oct; 185(7):4118-27. PubMed ID: 20833837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting of microvillus protein Eps8 by the NleH effector kinases from enteropathogenic
    Pollock GL; Grishin AM; Giogha C; Gan J; Oates CV; McMillan PJ; Gaeta I; Tyska MJ; Pearson JS; Scott NE; Cygler M; Hartland EL
    Proc Natl Acad Sci U S A; 2022 Aug; 119(34):e2204332119. PubMed ID: 35976880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and regulation of the Escherichia coli O157:H7 effector proteins NleH1 and NleH2.
    Holmes A; Lindestam Arlehamn CS; Wang D; Mitchell TJ; Evans TJ; Roe AJ
    PLoS One; 2012; 7(3):e33408. PubMed ID: 22428045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial cells detect functional type III secretion system of enteropathogenic Escherichia coli through a novel NF-κB signaling pathway.
    Litvak Y; Sharon S; Hyams M; Zhang L; Kobi S; Katsowich N; Dishon S; Nussbaum G; Dong N; Shao F; Rosenshine I
    PLoS Pathog; 2017 Jul; 13(7):e1006472. PubMed ID: 28671993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The type III effectors NleE and NleB from enteropathogenic E. coli and OspZ from Shigella block nuclear translocation of NF-kappaB p65.
    Newton HJ; Pearson JS; Badea L; Kelly M; Lucas M; Holloway G; Wagstaff KM; Dunstone MA; Sloan J; Whisstock JC; Kaper JB; Robins-Browne RM; Jans DA; Frankel G; Phillips AD; Coulson BS; Hartland EL
    PLoS Pathog; 2010 May; 6(5):e1000898. PubMed ID: 20485572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The type III secretion effector NleF of enteropathogenic Escherichia coli activates NF-κB early during infection.
    Pallett MA; Berger CN; Pearson JS; Hartland EL; Frankel G
    Infect Immun; 2014 Nov; 82(11):4878-88. PubMed ID: 25183730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Escherichia coli virulence protein NleH1 interaction with the v-Crk sarcoma virus CT10 oncogene-like protein (CRKL) governs NleH1 inhibition of the ribosomal protein S3 (RPS3)/nuclear factor κB (NF-κB) pathway.
    Pham TH; Gao X; Singh G; Hardwidge PR
    J Biol Chem; 2013 Nov; 288(48):34567-74. PubMed ID: 24145029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional Characterization of EscK (Orf4), a Sorting Platform Component of the Enteropathogenic Escherichia coli Injectisome.
    Soto E; Espinosa N; Díaz-Guerrero M; Gaytán MO; Puente JL; González-Pedrajo B
    J Bacteriol; 2017 Jan; 199(1):. PubMed ID: 27795324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T3SS-Independent Uptake of the Short-Trip Toxin-Related Recombinant NleC Effector of Enteropathogenic
    Stolle AS; Norkowski S; Körner B; Schmitz J; Lüken L; Frankenberg M; Rüter C; Schmidt MA
    Front Cell Infect Microbiol; 2017; 7():119. PubMed ID: 28451521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamics of expression, secretion and translocation of type III effectors during enteropathogenic Escherichia coli infection.
    Serapio-Palacios A; Finlay BB
    Curr Opin Microbiol; 2020 Apr; 54():67-76. PubMed ID: 32058947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A distinct regulatory sequence is essential for the expression of a subset of nle genes in attaching and effacing Escherichia coli.
    García-Angulo VA; Martínez-Santos VI; Villaseñor T; Santana FJ; Huerta-Saquero A; Martínez LC; Jiménez R; Lara-Ochoa C; Téllez-Sosa J; Bustamante VH; Puente JL
    J Bacteriol; 2012 Oct; 194(20):5589-603. PubMed ID: 22904277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intimate adherence by enteropathogenic Escherichia coli modulates TLR5 localization and proinflammatory host response in intestinal epithelial cells.
    Salazar-Gonzalez H; Navarro-Garcia F
    Scand J Immunol; 2011 Apr; 73(4):268-83. PubMed ID: 21204905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.